These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5368600)

  • 1. The value of forced inspirogram for estimating reversibility of ventilatory impairment chronic obstructive lung disease.
    Kalacić I
    Arh Hig Rada Toksikol; 1969; 20(2):155-9. PubMed ID: 5368600
    [No Abstract]   [Full Text] [Related]  

  • 2. Simple ventilatory tests for assessing response to bronchodilator in chronic obstructive pulmonary disease.
    Sobol BJ; Emirgil C; Wadhwani B; Goyal P
    Anesth Analg; 1972; 51(1):21-6. PubMed ID: 5061719
    [No Abstract]   [Full Text] [Related]  

  • 3. The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD.
    Ben Saad H; Préfaut C; Tabka Z; Zbidi A; Hayot M
    Pulm Pharmacol Ther; 2008 Oct; 21(5):767-73. PubMed ID: 18555715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoetharine and salbutamol--a comparative bronchodilator trial.
    Chapman TT; De Wytt C
    J Ir Med Assoc; 1971 Mar; 64(407):137-40. PubMed ID: 4932017
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of bronchodilator aerosols on single-breath ("effective") lung volumes in patients with chronic non-allergic obstructive lung disease.
    Teculescu D
    Rev Roum Med Intern; 1972; 9(6):559-67. PubMed ID: 4571831
    [No Abstract]   [Full Text] [Related]  

  • 6. The uses of simple spirometry.
    Sobol BJ; Emirgil C
    Ann Allergy; 1975 Jan; 34(1):34-40. PubMed ID: 1155819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spirometry in assessing non-obstructive ventilatory impairment.
    Webster IW
    Respiration; 1974; 31(2):97-104. PubMed ID: 4820835
    [No Abstract]   [Full Text] [Related]  

  • 8. Forced expiratory flows' contribution to lung function interpretation in schoolchildren.
    Boutin B; Koskas M; Guillo H; Maingot L; La Rocca MC; Boulé M; Just J; Momas I; Corinne A; Beydon N
    Eur Respir J; 2015 Jan; 45(1):107-15. PubMed ID: 25186269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue viscance in chronic obstructive lung disease.
    Ishikawa S; Cherniack RM
    Am Rev Respir Dis; 1971 Jul; 104(1):32-40. PubMed ID: 5556232
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the action of salbutamol and of isoprenaline on airway resistance in 30 patients with obstructive airways disease.
    Sadoul P; Sentissi M
    Postgrad Med J; 1971 Mar; 47():Suppl:111-2. PubMed ID: 5572508
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of response of spirometric indices to bronchodilator drugs in patients with obstructive lung disease.
    Snider GL; Shapiro DA
    Am J Med Sci; 1965 Oct; 250(4):367-73. PubMed ID: 5840934
    [No Abstract]   [Full Text] [Related]  

  • 12. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease.
    Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD.
    Molimard M; Bourcereau J; Le Gros V; Bourdeix I
    Respir Med; 2005 Jun; 99(6):695-702. PubMed ID: 15878485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function and work status. Patients and disability applicants.
    Silver HM
    Am J Phys Med; 1967 Oct; 46(5):1384-93. PubMed ID: 6054553
    [No Abstract]   [Full Text] [Related]  

  • 16. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Office spirometry].
    Bloch KE
    Praxis (Bern 1994); 2003 Sep; 92(39):1617-24. PubMed ID: 14558429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vital capacity of the lungs during chronic suppurative lung diseases].
    Kukosh VI; Zakharov SN
    Vestn Khir Im I I Grek; 1970 Dec; 105(12):3-5. PubMed ID: 5514429
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlative aspects of spirographic, oximetric and zonal ventilation-perfusion ratio findings in chronic obstructive bronchopneumopathy. I. Some comparative oximetric and ventilatory data in evaluation of the effectiveness of bronchodilator treatment].
    Fica V; Stănescu L; Olteanu D; Mătrescu F; Andronescu D; Ionescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(2):149-56. PubMed ID: 17907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.